Tuesday, September 27, 2016
Dear SITC Members,
SITC represents professionals in the field of tumor immunology and cancer immunotherapy. As SITC members, we are at the forefront of recent breakthroughs in immunotherapy that are rapidly changing the clinical practice of cancer care. Our close relationship and interaction with the US Food and Drug Administration (FDA) and other regulatory agencies are more critical than ever as we navigate the significant progress occurring in the field.
In order to best position the society, we are seeking your input on ways in which we can continue to engage with regulatory agencies in the most appropriate manner. We are also interested in obtaining your input on the most important regulatory issues facing the academic, community and industry environments with respect to immunotherapy drug development and clinical practice.
Please take 5-10 minutes to complete the following questionnaire by Tuesday, October 4, 2016 at midnight EST. I appreciate your input and suggestions.
Respectfully,
.jpeg)
Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org
© 2016 Society for Immunotherapy of Cancer
Join us on:
If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.
Please add info@sitcancer.org to your safe senders list.